Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN967890 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Annexin A6 (ANXA6) (AA 1-673) antibody
- Antibody type
- Monoclonal
- Antigen
- Human Annexin VI
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- 73
- Vial size
- 50 µg
- Concentration
- 250 µg/ml
- Storage
- Store undiluted at -20°C.
Submitted references Identification of novel markers for monitoring minimal residual disease in acute lymphoblastic leukemia.
Annexins in cell membrane dynamics. Ca(2+)-regulated association of lipid microdomains.
Phosphatidylinositide 3-kinase localizes to cytoplasmic lipid bodies in human polymorphonuclear leukocytes and other myeloid-derived cells.
Annexin VI participates in the formation of a reversible, membrane-cytoskeleton complex in smooth muscle cells.
Diversity in the lipocortin/calpactin family.
Chen JS, Coustan-Smith E, Suzuki T, Neale GA, Mihara K, Pui CH, Campana D
Blood 2001 Apr 1;97(7):2115-20
Blood 2001 Apr 1;97(7):2115-20
Annexins in cell membrane dynamics. Ca(2+)-regulated association of lipid microdomains.
Babiychuk EB, Draeger A
The Journal of cell biology 2000 Sep 4;150(5):1113-24
The Journal of cell biology 2000 Sep 4;150(5):1113-24
Phosphatidylinositide 3-kinase localizes to cytoplasmic lipid bodies in human polymorphonuclear leukocytes and other myeloid-derived cells.
Yu W, Cassara J, Weller PF
Blood 2000 Feb 1;95(3):1078-85
Blood 2000 Feb 1;95(3):1078-85
Annexin VI participates in the formation of a reversible, membrane-cytoskeleton complex in smooth muscle cells.
Babiychuk EB, Palstra RJ, Schaller J, Kämpfer U, Draeger A
The Journal of biological chemistry 1999 Dec 3;274(49):35191-5
The Journal of biological chemistry 1999 Dec 3;274(49):35191-5
Diversity in the lipocortin/calpactin family.
Crompton MR, Moss SE, Crumpton MJ
Cell 1988 Oct 7;55(1):1-3
Cell 1988 Oct 7;55(1):1-3
No comments: Submit comment
No validations: Submit validation data